Study of the Link Between Freezing of Gait and Oropharyngeal Freezing in Parkinson's Patients Trial N/A Recruiting Dec. 3, 2024
A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders Trial Phase 2 Completed Dec. 1, 2024
A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418 Trial Phase 1 Recruiting Dec. 1, 2024
Multimodal Image Technologies Investigate the Role and Mechanism of Probiotics in Improving RBD with Parkinson's Disease Trial Phase 4 Recruiting Dec. 1, 2024
Deep Brain Stimulation (DBS) of the Pedunculopontine Nucleus (PPN) Trial N/A Enrolling by invitation Nov. 28, 2024
Parkinson's Repository of Biosamples and Network Datasets (Tracking Parkinson's) Trial N/A Completed Nov. 28, 2024
West Sweden Parkinson Objective Measurement Registry Study Trial N/A Active, not recruiting Nov. 26, 2024
Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease Trial N/A Recruiting Nov. 24, 2024
Vibrotactile Coordinated Reset for the Treatment of Post Surgery Refractory Parkinson's Disease Patients Trial N/A Not yet recruiting Nov. 24, 2024
A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease Trial Phase 2 Not yet recruiting Nov. 24, 2024
teleRehabilitation for pAtients With ParkInson's Disease at Any mOment Trial N/A Completed Nov. 21, 2024
Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease Trial Phase 1 Not yet recruiting Nov. 20, 2024
Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers Trial N/A Completed Nov. 20, 2024
The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders Trial N/A Recruiting Nov. 20, 2024
A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Conditional Labeling Trial N/A Completed Nov. 19, 2024
An Observational Study of Patients Living With Chronic Neurological Diseases Trial N/A Not yet recruiting Nov. 19, 2024